AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16209203
Drug: Routine medication
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medication plus psychologic treatment
Trial: 9644786
Drug: Epirubicin (EPI)
DrugBank: Epirubicin (DB00445)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epirubicin (EPI) 20 mg/40 ml
Trial: 9644786
Drug: Epirubicin (EPI)
DrugBank: Epirubicin (DB00445)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epirubicin (EPI) 50 mg/100 ml
Trial: 3366160
Drug: Cimetropium bromide
RxNorm normalized name: cimetropium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetropium bromide (5 mg i.v.)
Trial: 31487739
Drug: Flurbiprofen axetil
RxNorm normalized name: Flurbiprofen axetil
DrugBank: Flurbiprofen axetil (DB14938)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen axetil (50 mg, i.v.)
Trial: 31487739
Drug: Intralipid (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid (0.1 mL/kg, i.v.)
Trial: 28667201
Drug: Cognitive processing
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive processing therapy (CPT) in conjunction with treatment as usual (mostly pharmacotherapy and clinical monitoring)
Trial: 3552360
Drug: Fluradoline, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluradoline, 300 mg
Trial: 3552360
Drug: Fluradoline, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluradoline, 150 mg
Trial: 24929459
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection of phylloquinone (vitamin K1) in SP6
Trial: 22587416
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy plus concurrent chemoradiotherapy (69 patients)
Trial: 9928561
Drug: Primary endocrine
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary endocrine therapy
Trial: 7706955
Drug: Phasic exercises
RxNorm normalized name: insulin isophane, pork / insulin, regular, pork Injectable Suspension [Hypurin Porcine Biphasic Isophane]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phasic exercises and chiropractic therapy (Group 2, n = 15)
Trial: 7706955
Drug: Standard exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard exercises (stretching/isometric/isokinetic) and chiropractic therapy (Group 1, n = 15)
Trial: 2533024
Drug: Flunoxaprofen 400
RxNorm normalized name: flunoxaprofen
DrugBank: Flunoxaprofen (DB13317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunoxaprofen 400 mg/day p.o. for 30 days
Trial: 2533024
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg/day p.o. for 30 days
Trial: 31811645
Drug: DPBM with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPBM with adjunctive use of EMD (test group, n = 20)
Trial: 25400471
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate tablets (NaP, CLICOLONTM)
Trial: 25400471
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol solution (PEG)
Trial: 18646498
Drug: Meloxicam pre‐emptively
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam pre‐emptively administered
Trial: 6610580
Drug: Fenbufen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenbufen (600 mg)
Trial: 27695824
Drug: Hydrocortisone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (200 mg continuous infusion for 5 days, followed by tapering until day 11)
Trial: 23726851
Drug: Pramipexole (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (1.5 mg a day)
Trial: 21849596
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg docosahexaenoic acid (DHA) + 150 mg eicosapentaenoic acid (fish oil)
Trial: 21849596
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg 5-methyltetrahydrofolate (5-MTHF)
Trial: 9762492
Drug: Direct with
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct with indirect therapy
Trial: 2108889
Drug: 3.75 or
RxNorm normalized name: Zileze 3.75 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 or 7.5 mg leuprorelin acetate depot given subcutaneously once every 4 weeks
Trial: 7001332
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E therapy (25 mg daily by mouth for the first six weeks of life)
Trial: 26059696
Drug: Chemotherapy compliance
RxNorm normalized name: ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Chemotherapy compliance reporting
Trial: 23934621
Drug: GSK1521498 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1521498 20 mg
Trial: 23934621
Drug: GSK1521498 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1521498 20 mg + Ethanol 0.5 g/kg body weight
Trial: 21367761
Drug: Chondroitin sulphate
RxNorm normalized name: Chondroitin sulphate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulphate (CS) 800 mg once daily for 6 months
Trial: 15126148
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sildenafil (Viagra)
Trial: 11217092
Drug: Ninjin-to (6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ninjin-to (6.0 g)
Trial: 9448590
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids and oral cyclophosphamide (CY; 2 mg/kg/day) for 1 yr (group A)
Trial: 9448590
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids and monthly i.v. CY pulses (0.6 g/m2) for 1 yr (group B)
Trial: 384188
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plus chemotherapy
Trial: 25758370
Drug: Zn +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zn + Se (ZS; 30 mg Zn as zinc‐gluconate and 200 μg Se as high‐selenium yeast)
Trial: 23628045
Drug: Combined drug
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug group treated with corticosteroid and anti-helicobacter pylori treatment
Trial: 23628045
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug group treated only with corticosteroid
Trial: 18771564
Drug: Daily supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplement of 800 IU vitamin D from 27 weeks until delivery
Trial: 18771564
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 200,000 IU vitamin D
Trial: 15054378
Drug: Pentoxifylline (Ptx)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (Ptx) 400 mg 3 times a day orally (total 1200 mg)
Trial: 9597571
Drug: Intermediate-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose cyclophosphamide (2 g/m2), etoposide (600 mg/m2), and G-CSF 6 micrograms/kg/day (ID-Cy)
Trial: 9597571
Drug: High-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide (4 g/m2), etoposide (600 mg/m2), and G-CSF 6 micrograms/kg/day (HD-Cy)
Trial: 9597571
Drug: High-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide (HD-Cy)
Trial: 9597571
Drug: Intermediate-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose cyclophosphamide (ID-Cy)
Trial: 8062773
Drug: Plasma derived
RxNorm normalized name: c1-inhibitor, plasma derived
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma derived HB vaccine
Trial: 8062773
Drug: Recombinant HB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant HB vaccine
Trial: 2890903
Drug: GLP-1 7-36
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 7-36 infusion
Trial: 29742960
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg twice-daily
Trial: 16875644
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen/medroxyprogesterone acetate [0.625/2.5 mg]
Trial: 1510005
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of insulin (0.1 U/kg body weight 4 times a day for 7 days)
Trial: 1510005
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of insulin
Trial: 1510005
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of insulin (once, n = 6)
Trial: 29610982
Drug: Both agents
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both agents (Gluma and Duraphat)
Trial: 27310945
Drug: Normal temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal temperature solution
Trial: 17472001
Drug: Cernilton for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton for 3 months + antibacterial treatment for 8 months (group IIa)
Trial: 17472001
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic treatment for 2 months maximally (group IIb)
Trial: 12086555
Drug: Anakinra (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (human recombinant interleukin‐1 receptor antagonist)
Trial: 12086555
Drug: Anakinra (monotherapy)
RxNorm normalized name: anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anakinra (monotherapy)
Trial: 12086555
Drug: Anakinra plus
RxNorm normalized name: anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anakinra plus methotrexate (combination therapy)
Trial: 7899379
Drug: Aspirin 900
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 900 mg-metoclopramide 10 mg effervescent association (AAM)
Trial: 28751548
Drug: Pioglitazone 15-30
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 15-30 mg
Trial: 19341122
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBO2) with N-acetylcysteine (NAC)
Trial: 19341122
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBO2) without N-acetylcysteine (NAC)
Trial: 15490811
Drug: letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: letrozole 2.5 mg
Trial: 15490811
Drug: anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anastrozole 1 mg
Trial: 11557681
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (1 mg 17beta‐estradiol combined with 0.5 mg norethisterone acetate)
Trial: 9786808
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) for 10 weeks
Trial: 9786808
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no specific antidepressant treatment)
Trial: 7973171
Drug: Incentives, enablers,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentives, enablers, medication monitors, and chemotherapeutic regimens allowing direct administration of medication combined with effective patient-physician relationship
Trial: 7973171
Drug: Traditional health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional health education and medication labeling methods
Trial: 28371900
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low nicotine content (VLNC; 2.4 mg/g nicotine or less) cigarettes
Trial: 28371900
Drug: Normal nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal nicotine content (NNC; 15.8 mg/g) cigarettes
Trial: 26601156
Drug: AAV9-IGHMBP2 administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AAV9-IGHMBP2 administration via systemic injection
Trial: 26601156
Drug: AAV9-IGHMBP2 administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AAV9-IGHMBP2 administration in human SMARD1-induced pluripotent stem cell-derived motor neurons
Trial: 23967638
Drug: Botox group
RxNorm normalized name: Botox
DrugBank: DaxibotulinumtoxinA (DB17929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botox group (local injection of botox type A)
Trial: 19596010
Drug: Amitriptyline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10 mg/d for weight <35 kg; 20 mg/d for weight >35 kg)
Trial: 16705580
Drug: Oral probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral probiotic Lactobacillus casei subspecies rhamnosus (6 x 10^9 cfu/day) added to human milk
Trial: 29343509
Drug: Tregalizumab 25
RxNorm normalized name: Tregalizumab
DrugBank: Tregalizumab (DB13073)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tregalizumab 25 mg
Trial: 29343509
Drug: Tregalizumab 100
RxNorm normalized name: Tregalizumab
DrugBank: Tregalizumab (DB13073)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tregalizumab 100 mg
Trial: 29343509
Drug: Tregalizumab 200
RxNorm normalized name: Tregalizumab
DrugBank: Tregalizumab (DB13073)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tregalizumab 200 mg
Trial: 26811968
Drug: CHoBI7 intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHoBI7 intervention (hand washing with soap and water treatment)
Trial: 24980662
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 200,000 IU for 2 months followed by 100,000 IU monthly for 18 months
Trial: 17636181
Drug: Spa treatment
RxNorm normalized name: Salicylic Acid 5 mg in 1 mL TOPICAL LOTION [ageLOC LumiSpa Treatment Cleanser Acne]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa treatment course in Tunisia
Trial: 12443741
Drug: Lignocaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine (5 ml of 1% lignocaine)
Trial: 12443741
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline placebo (5 ml)
Trial: 10502216
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus accelerated tissue plasminogen activator (TPA)
Trial: 7206052
Drug: 5-fluorouracil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil (600 mg per M², administered intravenously weekly)
Trial: 29174928
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g IN
Trial: 29174928
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g IN
Trial: 29174928
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g IN
Trial: 21557777
Drug: Intralesional cryosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional cryosurgery with pain-control protocol (oral pain-relief tablets Dipyrone and translesional local anaesthesia with Bupivacaine hydrochloride 0.5%)
Trial: 17688080
Drug: Monodoks 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monodoks 100 mg capsule (test preparation)
Trial: 17688080
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg capsule of the originator product (reference preparation)
Trial: 12443524
Drug: Combined physiotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined physiotherapy program (manual therapy, exercise, education)
Trial: 7852490
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) therapy (0.04 +/- 0.01 IU/kg daily)
Trial: 2045853
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no specific antibody mentioned)
Trial: 6988941
Drug: Liquid antacid
RxNorm normalized name: GNP Liquid Antacid Maximum Strength 400mg-400mg-40mg/5ml Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid antacid preparation (Link)
Trial: 30939085
Drug: Minimal-effect treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal-effect treatment
Trial: 21544313
Drug: edoxaban 30
RxNorm normalized name: edoxaban 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edoxaban 30 mg
Trial: 21544313
Drug: edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edoxaban 60 mg
Trial: 21544313
Drug: edoxaban 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edoxaban 120 mg
Trial: 21544313
Drug: fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fondaparinux 2.5 mg
Trial: 17956811
Drug: Auditory discrimination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auditory discrimination therapy (ADT)
Trial: 9162303
Drug: DFMO 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFMO 0.125 g/day
Trial: 9162303
Drug: DFMO 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFMO 0.25 g/day
Trial: 9162303
Drug: DFMO 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFMO 0.5 g/day
Trial: 9162303
Drug: DFMO 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFMO 1.0 g/day
Trial: 9162303
Drug: DFMO doses
RxNorm normalized name: DFMO
DrugBank: Eflornithine (DB06243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DFMO doses of > or = 1 g/day
Trial: 24843313
Drug: Oxycodone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (1 mg) and ketorolac (1.5 mg)
Trial: 24843313
Drug: Fentanyl (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (10 mcg) and ketorolac (1.5 mg)
Trial: 24843313
Drug: Oxycodone and
RxNorm normalized name: oxycodone and naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone and Fentanyl
Trial: 16533870
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg before CS/US pairing
Trial: 16533870
Drug: Flumazenil 1
RxNorm normalized name: flumazenil 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil 1 mg before conditioning
Trial: 16533870
Drug: Flumazenil 1
RxNorm normalized name: flumazenil 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil 1 mg after conditioning
Trial: 15448917
Drug: Therapy for
RxNorm normalized name: nutritional therapy for GSD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy for BPD
Trial: 11876690
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha-2b (10 MU daily for 10 days, then 5 MU daily for 74 days, then 5 MU three times weekly for 24 weeks)
Trial: 11876690
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha-2b with ribavirin (1000-1200 mg/day starting at day 11)
Trial: 11876690
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha-2b
Trial: 10215775
Drug: Intermittent therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent therapy (200 mg twice daily for 1 week per month for 3 months)
Trial: 10215775
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy (200 mg once daily for 3 months)
Trial: 7759273
Drug: music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: music therapy
Trial: 7759273
Drug: music-video therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: music-video therapy
Trial: 2186658
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with fentanyl 100 mcg
Trial: 29310376
Drug: Fentanyl 25 μg
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl 25 μg and morphine 100 μg (FM group)
Trial: 29310376
Drug: Morphine 100 μg
RxNorm normalized name: morphine sulfate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 100 μg (M group)